EGCG-Zinc Nanocomplex Suppository Shields Rectal Tissue from Radiation Damage
A thermosensitive rectal suppository combining EGCG and zinc nanoparticles dramatically reduces radiation-induced proctitis in mice by cutting oxidative stress, inflammation, and barrier damage.
Summary
Radiation therapy for pelvic cancers causes proctitis in over 70% of patients, yet effective local treatments remain scarce. Researchers at Zhejiang Cancer Hospital developed a rectal suppository containing EGCG-Zinc nanocomplexes, where zinc coordinates with green tea's key antioxidant polyphenol to dramatically improve its stability. The suppository melts at body temperature, releasing the nanocomplex directly into rectal tissue. In irradiated mice, it outperformed free EGCG, zinc alone, and their simple mixture in reducing oxidative stress, DNA damage, and inflammatory signaling. It also restored tight junction proteins and promoted epithelial regeneration. Mechanistically, the treatment suppressed MAPK inflammatory signaling and activated Rap1 pathways governing mucosal barrier repair, with no detectable local or systemic toxicity across repeated dosing.
Detailed Summary
Radiation-induced proctitis (RIP) affects more than 70% of patients receiving pelvic radiotherapy for cancers such as colorectal, cervical, and prostate malignancies. The condition ranges from acute diarrhea and rectal bleeding to chronic ulcers, strictures, and perforation. Current treatments — corticosteroid enemas, sucralfate, 5-aminosalicylic acid preparations — provide incomplete relief and suffer from poor rectal retention and inadequate local drug concentrations. This study addressed that gap by engineering a purpose-built localized delivery system combining two complementary bioactive agents into a single suppository formulation.
The team synthesized EGCG-Zinc (EGCG-Zn) nanocomplexes by coordinating Zn²⁺ ions with the phenolic hydroxyl groups of epigallocatechin gallate (EGCG), the primary antioxidant polyphenol in green tea. Characterization confirmed successful coordination via UV-VIS redshift and broadening (300–400 nm chelation bands), FTIR shifts at the O–H (~3400 cm⁻¹) and C=O (~1600 cm⁻¹) stretching bands, and XPS confirmation of Zn 2p signals with altered O 1s binding energy. XRD showed an amorphous structure, reflecting multi-site coordination that disrupts crystalline ordering. DLS revealed a hydrated diameter of ~190 nm with a PDI of 0.191 and a zeta potential of −19.26 mV, indicating stable colloidal dispersion. TGA combined with ICP-MS showed the nanocomplex comprised approximately 73 wt% EGCG and 28 wt% zinc (Zn/EGCG molar ratio ~1:3). Critically, EGCG-Zn retained equivalent radical scavenging capacity (ABTS and DPPH assays) to free EGCG while dramatically outperforming it under varying pH and thermal conditions simulating the intestinal environment — where free EGCG rapidly degraded.
In vitro, normal human intestinal epithelial cells (HCoEpiC) tolerated EGCG-Zn with excellent biocompatibility across multiple concentrations, substantially better than zinc salt alone or a physical mixture. After 6 Gy X-ray irradiation, EGCG-Zn most potently suppressed intracellular ROS accumulation versus free EGCG, the mixture, and zinc alone. Colony formation assays confirmed preferential radioprotection in normal epithelial cells, and the nanocomplex significantly attenuated radiation-induced DNA double-strand breaks (γ-H2AX foci), inflammatory cytokine release, and caspase-mediated apoptosis in irradiated cells.
The nanocomplex was then incorporated into a thermosensitive rectal suppository base (PEG-100 stearate/PEG). The suppository remained solid below body temperature, melted at rectal temperature (~37°C), and provided prolonged mucosal residence. In an irradiated mouse model of RIP, EGCG-Zn suppositories significantly reduced rectal oxidative stress markers (SOD, MDA, CAT), DNA damage (γ-H2AX), and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) compared to vehicle controls and all comparator groups including free EGCG and EGCG+Zn mixture. Histological analyses confirmed preserved crypt architecture, restored goblet cell populations, and maintained tight junction protein expression (ZO-1, claudin-1, occludin). Transcriptomic analysis implicated inhibition of MAPK/NF-κB inflammatory and apoptotic signaling alongside activation of the Rap1 pathway, which governs adherens junction and mucosal barrier remodeling.
Safety profiling across repeated rectal administrations revealed no detectable local mucosal toxicity, systemic organ damage, or hematological abnormalities. The suppository form bypasses gastrointestinal degradation, limits systemic absorption, and maximizes local drug concentrations — addressing the core limitations of oral and enema-based EGCG delivery. While results are currently limited to a mouse model and mechanistic validation will require human trials, the simplicity of the formulation (food-derived polyphenol plus essential mineral in a standard suppository base) offers a favorable safety and regulatory profile for clinical translation.
Key Findings
- EGCG-Zn nanocomplexes (~190 nm, PDI 0.191, zeta −19.26 mV) retained equivalent ABTS/DPPH radical scavenging activity to free EGCG while maintaining stability under varying pH and temperature conditions where free EGCG rapidly degraded
- Nanocomplex composition confirmed at ~73 wt% EGCG and ~28 wt% zinc (Zn/EGCG molar ratio ~1:3) by combined TGA and ICP-MS analysis
- In irradiated HCoEpiC cells (6 Gy), EGCG-Zn most potently suppressed intracellular ROS accumulation, outperforming free EGCG, zinc alone, and a physical EGCG+Zn mixture
- EGCG-Zn suppositories significantly reduced rectal inflammatory cytokines (TNF-α, IL-6, IL-1β), oxidative stress markers (MDA, SOD, CAT), and γ-H2AX DNA damage foci in irradiated mice versus all comparators
- Histological analyses showed restored crypt architecture, goblet cell populations, and tight junction protein expression (ZO-1, claudin-1, occludin) in EGCG-Zn-treated animals
- Transcriptomic analysis identified dual mechanism: suppression of MAPK/NF-κB inflammatory and apoptotic signaling combined with activation of the Rap1 mucosal barrier repair pathway
- No detectable local mucosal or systemic toxicity observed after repeated rectal administrations in mice, including normal hematological and organ parameters
Methodology
The study employed in vitro experiments using human intestinal epithelial cells (HCoEpiC) irradiated at 6 Gy, and an in vivo radiation-induced proctitis mouse model with multiple treatment groups (vehicle, free EGCG, Zn salt alone, EGCG+Zn mixture, and EGCG-Zn suppository). Material characterization used SEM, HAADF-STEM/EDS, XRD, FTIR, XPS, TGA, ICP-MS, and DLS. Efficacy endpoints included ROS assays, colony formation, γ-H2AX foci counting, ELISA for cytokines, oxidative stress markers, histology with immunofluorescence for tight junction proteins, and RNA transcriptomics. Safety was assessed via repeated-dose rectal administration with hematological and histopathological evaluation.
Study Limitations
The study is currently limited to mouse models, and direct translation to human rectal anatomy, microenvironment, and radiation dosing protocols requires dedicated clinical trials. The transcriptomic mechanistic findings are correlative and require further validation with pathway-specific inhibitors. No conflicts of interest were declared by the authors, though the research was funded by multiple Chinese national and provincial science foundations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: